Target intelligence / Profile preview

Potassium two pore domain channel subfamily K member 15 (KCNK15)

Target
KCNK15
Molecular classification
Ion channel, Potassium channel, Two pore domain potassium channel (K2P channel)
01

Overview

Potassium two pore domain channel subfamily K member 15 (KCNK15, also known as TASK-5) is a member of the two pore domain potassium (K2P) channel family. While isolated KCNK15 (TASK-5) subunits do not form functional homomeric channels, they can form heteromeric channel complexes with TASK-1 and TASK-3, which then display unique electrophysiological and pharmacological properties. These heterodimers are found in various tissues, including the heart, vascular smooth muscle, pancreas, liver, lung, ovary, and testis. TASK-5 modulates the cell surface expression and function of TASK-1 and TASK-3 channels. Its unique association with physiological and disease processes, especially in cardiovascular disease, cancer, and sleep apnea, suggests emerging relevance as a therapeutic target, though there are currently no approved drugs targeting KCNK15 specifically. Key facts: - Not a functional potassium channel as a homodimer; requires co-assembly with TASK-1 or TASK-3 for activity. - Co-expression alters channel surface expression, conductance, and responsiveness to pharmacological modulators. - Genetic polymorphisms in KCNK15 may serve as biomarkers for patient stratification in TASK channel-targeted therapy.

Other names
TASK-5TASK5K2P15.1KT3.3DJ781B1.1Potassium channel, two pore domain subfamily K, member 15Acid-sensitive potassium channel protein TASK-5TWIK-related acid-sensitive K(+) channel 5
02

Mechanism of action

Modulation of potassium channel function via heteromeric complex formation (with TASK-1/TASK-3) can affect the pharmacological response and channel conductance properties. Gq-coupled receptor-mediated inhibition of heteromeric channels may be altered.

03

Biological functions

Potassium ion transportModulation of cellular excitabilityRegulation of membrane potentialRegulation of TASK-1 and TASK-3 channel trafficking and function (as heterodimer partner)
04

Disease associations

Cancer (role in malignancies; dysregulated in pancreatic, lung, thyroid, and hepatocellular carcinoma)Cardiovascular disease (implicated in atrial fibrillation and pulmonary arterial hypertension through heterodimer function)Sleep apnea (as part of TASK channel complex in respiratory function)Birk-Barel syndrome (gene association)
05

Safety considerations

Potential for tissue- and genotype-specific drug responses due to heteromeric channel formation and polymorphisms, influencing efficacy and adverse effect profilesRisks associated with non-specific targeting of TASK-1 channels when heterodimers are present (e.g., risk of pulmonary arterial hypertension when using some TASK-1 blockers)
06

Interacting drugs

No specific, clinically used drugs target KCNK15 directly; however, drugs targeting TASK-1 (e.g., activators and blockers, including BAY2586116) may interact with TASK-5/TASK-1 heterodimers
07

Biomarkers

Polymorphism TASK-5^G95E^ in KCNK15 may impact drug response and channel function in patients

Beyond the preview

Go deeper on Potassium two pore domain channel subfamily K member 15 (KCNK15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium two pore domain channel subfamily K member 15 (KCNK15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call